Bulletin
Investor Alert

New York Markets Close in:

Akero Therapeutics Inc.

NAS: AKRO

GO
/marketstate/country/us

Market open

/zigman2/quotes/212786461/composite

$

32.11

Change

-0.05 -0.14%

Volume

Volume 46,556

Sep 25, 2020, 1:55 p.m.

Real time quotes

/zigman2/quotes/212786461/composite

Previous close

$ 32.15

$ 32.11

Change

-0.05 -0.14%

Day low

Day high

$31.85

$32.81

Open
Open: 32.54

52 week low

52 week high

$10.78

$41.16

Open

Market cap

$1.12B

Average volume

187,506

P/E ratio

N/A

Rev. per Employee

N/A

EPS

-2.09

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/akro

MarketWatch News on AKRO

  1. Akero Therapeutics started at overweight with $70 stock price target at Morgan Stanley

    11:30 a.m. Sept. 10, 2020

    - Tomi Kilgore

  2. A Top Contender Drops Out of Race for a NASH Drug

    11:15 a.m. July 23, 2020

    - Barron's Online

  3. Akero Therapeutics initiated at buy with $79 price target at Chardan

    9:41 a.m. July 7, 2020

    - Tonya Garcia

  4. Akero Therapeutics started at buy with $36 stock price target at Canaccord Genuity

    1:14 p.m. Feb. 10, 2020

    - Tomi Kilgore

  5. Akero Therapeutics started at overweight with $28 stock price target at J.P. Morgan

    7:51 a.m. July 15, 2019

    - Tomi Kilgore

  6. Akero Therapeutics started at outperform with $35 stock price target at Evercore ISI

    7:42 a.m. July 15, 2019

    - Tomi Kilgore

/news/nonmarketwatch/company/us/akro

Other News on AKRO

  1. IPO Update: Metacrine Seeks $85 Million U.S. IPO

    2:58 p.m. Sept. 11, 2020

    - Seeking Alpha

  2. Viking Therapeutics: Another Year In Review

    2:39 p.m. Aug. 13, 2020

    - Seeking Alpha

  3. 10-Q: AKERO THERAPEUTICS, INC.

    4:53 p.m. Aug. 12, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  4. Biotech Bonanza - Second Half Outlook

    8:24 a.m. July 28, 2020

    - Seeking Alpha

  5. TTOO, MMLP, INO and BLNK among midday movers

    12:43 p.m. July 1, 2020

    - Seeking Alpha

  6. Akero Therapeutics (AKRO) Jumps: Stock Rises 8.9%

    9:03 a.m. July 1, 2020

    - Zacks.com

  7. FDX, BYND among premarket gainers

    8:11 a.m. July 1, 2020

    - Seeking Alpha

  8. Moving Average Crossover Alert: Akero Therapeutics

    10:30 a.m. June 10, 2020

    - Zacks.com

  9. 10-Q: AKERO THERAPEUTICS, INC.

    4:30 p.m. May 13, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  10. Loading more headlines...
/news/pressrelease/company/us/akro

Press Releases on AKRO

  1. Akero Therapeutics Reports Second Quarter 2020 Financial Results

    4:05 p.m. Aug. 12, 2020

    - PR Newswire - PRF

  2. Akero Therapeutics Appoints Tom Heyman to its Board of Directors

    8:00 a.m. June 10, 2020

    - PR Newswire - PRF

  3. Akero Therapeutics Reports First Quarter 2020 Financial Results

    4:05 p.m. May 13, 2020

    - PR Newswire - PRF

  4. venBio Closes $394 Million Life Sciences Venture Capital Fund

    8:00 a.m. April 3, 2020

    - BusinessWire - BZX

  5. Akero Therapeutics Completes Enrollment in Phase 2a Study in NASH

    5:05 p.m. Dec. 16, 2019

    - PR Newswire - PRF

  6. Loading more headlines...

Rates »

Link to MarketWatch's Slice.